Vascular最新文献

{"title":"Global trends in published research of aortic disease treatment: A two-decade bibliometric analysis (1994-2024).","authors":"Abubakar I Sidik, Sandro Lepidi, Kow Entsua-Mensah, Vladislav V Dontsov, Giovanni Badalamenti, Mario D'Oria","doi":"10.1177/17085381251379114","DOIUrl":"10.1177/17085381251379114","url":null,"abstract":"<p><p>BackgroundAortic diseases, including aneurysms and dissections, represent a significant global health burden, necessitating advancements in surgical and endovascular interventions. This bibliometric analysis examines the evolution of research trends, key contributors, and emerging themes in the treatment of aortic diseases over the past three decades.MethodsBibliometric data from Scopus and Web of Science databases were analyzed for peer-reviewed articles published between 1994 and 2024. A systematic approach adhering to the PRISMA 2020 framework identified 2985 articles. Descriptive and advanced bibliometric techniques, including citation, co-authorship, and keyword co-occurrence analyses, were employed using tools such as VOSviewer and Biblioshiny.ResultsThe annual scientific output demonstrated consistent growth, with significant contributions from the United States, United Kingdom, and Germany. Leading institutions, including Harvard Medical School and Beth Israel Deaconess Medical Center, played pivotal roles in advancing research. Keywords revealed a dual focus on minimally invasive techniques, such as EVAR and TEVAR, and patient-centered outcomes like quality of life and survival. Collaboration networks and citation analyses highlighted influential authors and foundational studies shaping the field.ConclusionsThe study underscores the importance of global collaboration and technological innovation in advancing aortic disease treatment. While disparities in research representation persist, emerging trends in hybrid approaches, multidisciplinary methods, and outcome-based studies offer promising directions for future research. These findings provide a comprehensive resource for clinicians, researchers, and policymakers seeking to address challenges and improve patient care in this critical field.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"511-524"},"PeriodicalIF":0.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145131996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Midterm results of catheter-directed thrombolysis combined with drug-coated balloon dilatation in the treatment of femoral-popliteal thromboangiitis obliterans.","authors":"Jianhuang Zhuang, Lei Wang, Meilin Liu, Songlin Guo, Zhang Zhang","doi":"10.1177/17085381251379324","DOIUrl":"10.1177/17085381251379324","url":null,"abstract":"<p><p>ObjectivesTo investigate the effect of catheter-directed thrombolysis (CDT) combined with drug-coated balloon (DCB) dilatation in the treatment of femoral-popliteal thromboangiitis obliterans (TAO).Materials and MethodsThe clinical data of 26 patients with femoral-popliteal TAO who underwent CDT combined with DCB dilatation were collected from April 2020 to November 2023. The clinical efficacy at different time points (preoperative, 24 hours postoperatively. and every 6-month intervals after the procedure) in terms of the pain score, Rutherford classification, and ankle-brachial index (ABI) was compared. The primary patency was assessed at 6 months and 1 year postoperatively. Amputation-free survival and limb salvage rate were also evaluated.ResultThe femoral-popliteal artery occlusions were successfully recanalized in all 26 patients. No complications such as thrombosis, rupture of vessel, and distal embolism occurred during the operation. Thrombolytic-related hemorrhage occurred in one patient. The pain score and Rutherford grade were lower and ABI was higher at 24 hours, 6 months, and 1 year postoperatively (<i>p</i> < .05). The primary patency rate was 88.5% (23/26) at 6 months and 65.3% (17/26) at 1 year postoperatively. Amputation-free survival and limb salvage rate were both 92.3% at 1 year.ConclusionThe efficacy of CDT therapy combined with DCB dilatation for femoral-popliteal thromboangiitis obliterans is acceptable at 6 months and 1 year, and the long-term effects need to be further observed.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"629-633"},"PeriodicalIF":0.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Interventional treatment for true aneurysm of superior mesenteric artery: A systematic review of the literature on open surgical strategies.","authors":"Laura Rascio, Nicolò Peluso, Domenico Pascucci, Lucia Mangiacotti, Ottavia Borghese, Yamume Tshomba","doi":"10.1177/17085381251379848","DOIUrl":"10.1177/17085381251379848","url":null,"abstract":"<p><p>BackgroundTrue aneurysms of the superior mesenteric artery (SMAA) are rare but clinically significant due to the risk of severe complications such as mesenteric ischemia and fatal hemorrhage upon rupture. While the European Society for Vascular Surgery (ESVS) recommends endovascular repair as the first-line treatment, open surgery remains a valuable option when endovascular repair is not feasible due to clinical or technical constraints.MethodA systematic literature review was conducted covering the period from 2010 to 2024. Twenty-five surgically treated SMAA cases were identified. Data were collected on patient characteristics, surgical indications, procedures performed, and clinical outcomes.ResultThe majority of patients were male (80%) with a mean age of 46 years. Indications for open repair included mycotic aneurysm (48%), collagenous disease or fibrodysplasia (20%), emergency repair for hemoperitoneum (4%), and unfavorable anatomy for endovascular treatment (28%). Surgical techniques included simple aneurysmectomy (56%) and aneurysm resection with graft reconstruction (44%). No intra- or postoperative bleeding or major complications were reported. In-hospital mortality was 16%, primarily due to acute bowel ischemia (12%). Among survivors, vascular reconstructions demonstrated 100% patency at a mean follow-up of 14 months (range 1-48 months), with no need for reintervention and no deaths during follow-up.ConclusionOpen surgical repair remains a viable treatment option in cases of infected SMAA, collagenous disease, or complex anatomy unsuitable for endovascular repair. It ensures satisfactory survival, favorable clinical outcomes, and durable mid-term patency without the need for reintervention.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"675-682"},"PeriodicalIF":0.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145056002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of endovascular kissing stent and aortobifemoral bypass in patients with aortoiliac occlusive disease.","authors":"Yusuf Kuserli, Ali Aycan Kavala, Hasan Toz, Gulsum Turkyilmaz, Onur Emre Satilmis, Saygin Turkyilmaz","doi":"10.1177/17085381251379120","DOIUrl":"10.1177/17085381251379120","url":null,"abstract":"&lt;p&gt;&lt;p&gt;ObjectiveTo compare endovascular kissing stent (KS) and aortobifemoral bypass (AFB) procedures in patients with bilateral common iliac artery occlusion.Materials and MethodsThis was a single-centre retrospective study. Subjects who underwent treatment for bilateral TASC II C and D common iliac artery occlusion between August 2013 and August 2021 with at least 3 years of follow-up were included in the study. The study group was divided into kissing stent (group A) and aortobifemoral bypass (group B) groups. The subjects' demographic data (including age, sex, body mass index (BMI), smoking history, comorbid diseases and medications), TransAtlantic Inter-Society Consensus (TASC) II classifications and Rutherford classifications were noted. Preoperative diagnostic data included ankle-brachial index (ABI) measurements and computed tomography (CT) angiography assessments of the aorta and iliac-femoral axis. Intraoperative data (including operative times and complications) and hospital stay data were recorded. Patients were evaluated at the 1&lt;sup&gt;st&lt;/sup&gt;, 3&lt;sup&gt;rd&lt;/sup&gt;, 6&lt;sup&gt;th&lt;/sup&gt;, 12&lt;sup&gt;th&lt;/sup&gt;, 24&lt;sup&gt;th&lt;/sup&gt; and 36&lt;sup&gt;th&lt;/sup&gt; months after the procedure at outpatient visits. The primary patency, primary-assisted patency and secondary patency rates were calculated.ResultsThis study included 120 cases. The mean age of the participants in the study group was 66.18 ± 4.63 years (range: 56-78). The BMI of group A was significantly greater than that of group B (23.13 ± 1.36 for group A and 21.51 ± 1.38 for group B, &lt;i&gt;p&lt;/i&gt; = 0.001) (Table 1). The rate of TASC D classification in group B was significantly greater than that in group A (&lt;i&gt;p&lt;/i&gt; = 0.001; &lt;i&gt;p&lt;/i&gt; &lt; 0.01). The operation time of group B was significantly greater than that of group A (mean of 56 min for group A and 210 min for group B, &lt;i&gt;p&lt;/i&gt; = 0.001). Moreover, the hospital stay of group B was significantly longer than that of group A (mean of 1 day for group A and 7 days for group B, &lt;i&gt;p&lt;/i&gt; = 0.001).For the follow-up CT angiography measurements, a significant difference was observed between the groups at the 24&lt;sup&gt;th&lt;/sup&gt; month of follow-up (&lt;i&gt;p&lt;/i&gt; = 0.023; &lt;i&gt;p&lt;/i&gt; &lt; 0.05). The rate of full patency in patients in group B was significantly greater than that in group A (&lt;i&gt;p&lt;/i&gt; = 0.027; &lt;i&gt;p&lt;/i&gt; &lt; 0.05). Additionally, the rate of 0%-50% stenosis in patients in group B was significantly lower than that in patients in group A (&lt;i&gt;p&lt;/i&gt; = 0.023; &lt;i&gt;p&lt;/i&gt; &lt; 0.05). Other comparisons, such as those for CT angiography measurements, were not significant (&lt;i&gt;p&lt;/i&gt; &gt; 0.05 for all comparisons). Eleven (&lt;i&gt;n&lt;/i&gt; = 11, 18.3%) out of sixty subjects in group A and seven (11.7%) out of sixty subjects in group B underwent secondary interventions (&lt;i&gt;p&lt;/i&gt; = 0.444). The calculated primary patency, primary-assisted patency and secondary patency rates at 36 months were 68.3%, 21.7% and 10% for group A and 83.3%, 11% and 6.7% for group B, respectively.ConclusionThe use of KS and AFB proced","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"693-701"},"PeriodicalIF":0.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145131985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tunnel-transposition with veno-venous or veno-arterial re-anastomosis versus skin-flap elevation for second-stage superficialization of brachiobasilic arteriovenous fistula.","authors":"Moustafa Mabrouk, Ahmed Fouda, Rasha Gawish, Mohammed ElKassaby","doi":"10.1177/17085381251379847","DOIUrl":"10.1177/17085381251379847","url":null,"abstract":"<p><p>IntroductionArteriovenous fistula is the preferred vascular access for patients with chronic kidney disease on hemodialysis. Brachiobasilic arteriovenous fistulas are valued for their durability and long-term patency in patients with unsuitable superficial venous anatomy. The basilic vein, located deeper within the arm, offers a larger diameter. However, due to its depth, surgical interventions like superficialization or transposition are necessary to make the vein accessible for routine cannulation. This study compares the outcomes of three different surgical techniques used during the second stage of brachiobasilic arteriovenous fistula superficialization.Patients and MethodsThis retrospective study analyzed data from patients who underwent a second-stage brachiobasilic arteriovenous fistula between January 2020 and February 2023. The procedure involved elbow brachiobasilic AVF, resulting in vein dilatation and arterialization, followed by superficialization using techniques like skin-flap elevation or tunnel-transposition with veno-venous re-anastomosis or veno-arterial re-anastomosis. Follow-ups included routine clinic visits, duplex ultrasound scans, and monthly surveillance visits.ResultsA study of 238 second-stage brachiobasilic arteriovenous fistula procedures revealed no significant differences among the three groups. The skin-flap elevation technique had shorter operative times and higher technical success rates but was associated with higher postoperative complications like hematomas, infections, and nerve injuries. The veno-venous re-anastomosis and veno-arterial re-anastomosis groups had lower complication rates, particularly nerve injuries and steal syndrome, but required longer operative times and had lower technical success rates.ConclusionSuperficial tunneling techniques provide better healing and less complications as compared to skin-flap elevation.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"717-724"},"PeriodicalIF":0.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145056021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Statin usage in patients with atherosclerotic occlusive vascular disease.","authors":"Mesut Engin, Enes Salih Altınsoy","doi":"10.1177/17085381261425736","DOIUrl":"10.1177/17085381261425736","url":null,"abstract":"","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"747-748"},"PeriodicalIF":0.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Can BlueDop be used as an alternative for diagnosing peripheral arterial disease? A prospective comparison of traditional ABPI and TBPI with BlueDop.","authors":"Lucy Fligelstone, Brenig Llwyd Gwilym, Melissa Blow, Julie Lee, Annie Clothier, Kristian Glover, Tracey Hutchings, David C Bosanquet","doi":"10.1177/17085381251359309","DOIUrl":"10.1177/17085381251359309","url":null,"abstract":"<p><p>ObjectivesAnkle and toe brachial pressure index are recommended globally as first line non-invasive screening tests for peripheral arterial disease. However, they can be inaccurate and have limited utility in patients with incompressible arteries, lower limb wounds and/or lack of digits. This study aims to evaluate BlueDop, a novel device that purports to assess peripheral perfusion without the need for a lower limb tourniquet or patients lying flat.MethodsPatients attending vascular and podiatry clinic at Aneurin Bevan University Health Board were recruited between May 2022 and May 2023. A BlueDop reading was recorded in addition to ankle and/or toe brachial pressure index. Satisfaction and preference of each method was recorded using an electronic proforma.Results176 patients were included. BlueDop ABPI was shown to be moderately correlated with cuff-ABPI (r_s = 0.42, <i>p</i> = .001) and weakly correlated with TBPI (r_s = 0.22, <i>p</i> = .04). BlueDop had moderate accuracy in diagnosing PAD (C statistic = 0.653) and was more accurate in diagnosing severe PAD (C statistic = 0.706). Diagnostic accuracy appeared to be improved when PAD was defined according to cuff-ABPI only. Patients were more satisfied with BlueDop (mean satisfaction score (MSS) = 4.33) compared to cuff-ABPI (MSS = 2.89, mean difference = 0.544, <i>p</i> < .001) and TBPI (MSS = 3.82, mean difference = 0.579, <i>p</i> < .001) while operator satisfaction was equal.ConclusionsThere is moderate correlation between BlueDop and cuff-ABPI. Patients prefer BlueDop to cuff-ABPI or TBPI. BlueDop appears to be an acceptable method of non-invasive assessment of PAD, although users must appreciate there is a discrepancy between it and cuff-ABPI/TBPI.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"612-619"},"PeriodicalIF":0.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144754427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prediction of all-cause mortality in endovascularly treated patients with peripheral arterial disease of the lower extremities.","authors":"Veronika Pavlíková, Martin Koščo, Marek Hudák, Jakub Čery, Barbara Čeryová, Mária Rašiová","doi":"10.1177/17085381251379804","DOIUrl":"10.1177/17085381251379804","url":null,"abstract":"<p><p>ObjectivesLower extremity peripheral arterial disease (PAD) is associated with increased morbidity and mortality. The primary objective of the study was to identify nonspecific risk factors for 2- and 5-year all-cause mortality in endovascularly treated patients with PAD. The secondary objective was to develop a clinically applicable scoring system to estimate the probability of 2- and 5-year all-cause mortality based on our results.MethodsWe performed a retrospective study using data from patients with PAD who underwent endovascular treatment between January 2016 and December 2018. All data were collected from electronic medical records. A Cox proportional hazards regression model was used to examine the association between variables and all-cause mortality. Multivariate analyses were performed after adjusting for age, chronic limb-threatening ischaemia (CLTI), creatinine and fibrinogen in model 1, and for age, hypertension, diabetes mellitus, sex, smoking, dyslipidemia, CLTI, chronic obstructive pulmonary disease, malignancy, atrial fibrillation, heart failure with reduced ejection fraction, coronary artery disease, fibrinogen and creatinine in model 2. Variables associated with mortality with p-value <.02 in all analyses were included in the scoring system. The predictive performance of the scoring system was evaluated using the Area Under Curve (AUC) of Receiver Operating Characteristic curve.ResultsA total of 676 patients with a mean age of 68.6 ± 9.74 years were analyzed, 66.7% of patients had CLTI. The 2-year mortality rate was 22.3%; 29.5% in patients with CLTI and 8% in patients with claudications. The 5-year mortality rate was 48.8%; 60.5% in patients with CLTI and 25.3% in patients with claudications. CLTI presence, creatinine, age and fibrinogen were included in the scoring system. Based on the cut-off values of creatinine >102.4 umol/l, fibrinogen >5.41 g/L, age ≥68 years and CLTI presence, patients were categorized into five groups. For 2-year mortality, a score of 0 points corresponded to a 5.0% risk of death, 1 point to an 11.1% risk, 2 points to a 23.0% risk, 3 points to a 41.7% risk and a score of 4 points to a 63.1% risk of death (AUC 0.73; p = .000). For 5-year mortality, a score of 0 points corresponded to a 13.5% risk of death, 1 point to a 31.3% risk, 2 points to a 57.1% risk, 3 points to a 79.5% risk and a score of 4 points to a 91.9% risk of death (AUC 0.74; p = .000).ConclusionsThe all-cause 2-year mortality rate in patients with PAD was 22.3%, and the 5-year mortality rate was 48.8%. The strongest associations with 2- and 5-year mortality were observed for CLTI presence, creatinine, age and fibrinogen. The scoring system based on these variables predicts 2- and 5-year all-cause mortality risk in patients with PAD, with a probability approaching 75%.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"658-668"},"PeriodicalIF":0.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145055966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ipsilateral third amputation following lower extremity index amputation for diabetic foot infection.","authors":"Kaissar Yammine, Mohammad Omar Honeine, Joseph Mouawad, Ghadi Abou Orm, Youssef Jamaleddine, Fady Hayek, Chahine Assi","doi":"10.1177/17085381251339235","DOIUrl":"10.1177/17085381251339235","url":null,"abstract":"<p><p>BackgroundLower extremity amputations (LEA) are serious complications of the infected diabetic foot. Subsequent amputations are underreported and the occurrence of an ipsilateral second re-amputation (third amputation) is unknown.MethodsThis is a retrospective study of a continuous series of patients admitted for LEA due to diabetic foot complications, with a minimum of 2 years of follow-up after the first re-amputation. A total of 111 patients comprising 149 index amputation; 97 and 52 cases in the minor and major type groups, respectively. The primary outcomes were the observed frequencies of first and second re-amputations with comparative analysis based on amputation type. Logistic regression analysis was used to look for independent risk factors.ResultsOut of 149 index LEA cases, 111 cases (74.5%) had no re-amputation. First re-amputation frequencies were 25.5%, 35%, and 7.7% for the whole sample, minor, and major groups, respectively. Second re-amputation frequencies were 34.2%, 31.6%, and 2.6% for the whole sample, minor, and major groups, respectively. Infection re-occurrence was the cause in 89.5% and 100% of cases for first and second re-amputation. Out of the 13 second re-amputation cases in the minor group, 30.7% were minor and 69.3% were major amputations. The mean time for the first re-amputation was 5.4 ± 9.4 months and that for the second re-amputation was 9.5 ± 7.1 months (<i>p</i> = .04). For the first re-amputation, independent risk factors were smoking (<i>p</i> = .04) and creatinine level (<i>p</i> = .02) outcome. For the second re-amputation outcome, male sex was the only independent variable (<i>p</i> = .03).ConclusionThis study demonstrated that a second re-amputation, mostly major, was needed in more than one-third among first re-amputation cases. Second re-amputation could be a relevant major endpoint outcome in this frail population.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"497-504"},"PeriodicalIF":0.9,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144020639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Minimally invasive management of varicose veins: Bridging the gap between traditional and modern methods.","authors":"Meghdad Ghasemi Gorji, Fatemeh Fakhraei, Ali Rafiei, Fardin Karbakhsh Ravari","doi":"10.1177/17085381251339234","DOIUrl":"10.1177/17085381251339234","url":null,"abstract":"<p><p>ObjectivesChronic venous disease (CVD) commonly presents as varicose veins, affecting a significant proportion of the population. Current treatments vary from invasive surgeries to advanced minimally invasive techniques, but many involve high costs and risk of complications. This study aimed to introduce and evaluate a novel, cost-effective technique combining high ligation of the great saphenous vein (GSV) with foam sclerotherapy, designed to minimize invasiveness, reduce complications, and improve patient outcomes.MethodsThe procedure began with ultrasound-guided mapping and marking of the GSV and perforating veins. Under local anesthesia, two small micro-incisions were created on the medial side of the leg. A double ligation was performed at the saphenofemoral junction using a 2-0 PDS suture, ensuring complete vein closure. Subsequently, the angiocatheters were inserted into the GSV above the perforators or in the mid-section of the vein if no perforators were present. Foam sclerotherapy was administered using a mixture of sodium tetradecyl sulfate, normal saline, and air. Compression bandaging was applied from the lower leg upward postoperatively. 18 patients were treated with this technique and followed up at 2 weeks, 3 months, and 6 months to assess clinical outcomes, complications, and recurrence.Results and ConclusionsThe novel technique demonstrated satisfied clinical outcomes with no reported complications, such as ecchymosis, hematoma, or discomfort, at the 2-week follow-up. No deep vein thrombosis (DVT) or recurrence cases were observed at the 3- and 6-month follow-ups. Our method reduced postoperative discomfort, bruising, and recovery time compared to traditional high ligation with stripping. Patients reported high satisfaction due to the minimally invasive nature and improved cosmetic results. Compared to thermal ablation methods, the technique was similarly effective but offered notable advantages in cost-effectiveness and accessibility, as it eliminated the need for expensive equipment or anesthesia. Future studies with larger sample sizes and extended follow-up periods are needed to validate these findings further, explore long-term recurrence rates, and refine patient selection criteria. This approach represents a promising, practical alternative for varicose vein treatment in diverse clinical settings.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"366-370"},"PeriodicalIF":0.9,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144000028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}